Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Reduced peroxisomal function increases insulin secretion, promotes insulin oxidation, and impairs β cell maturity
J. Jason Collier, Caroline R. Cothern, Maggie P. Ducote, Thomas M. Martin, Melissa A. Linden, Robert C. Noland, David H. Burk, Samuel D. Dupuy, Michael D. Karlstad, Krisztian Stadler, Sarah S. Hirschbeck, Thanh D. Do, Anastasia Coldren, Marcela Brissova, Teayoun Kim, Kirk M. Habegger, Sujoy Ghosh, Zane A. Vickery, Qudus Sarumi, Shawn R. Campagna, Susan J. Burke
J. Jason Collier, Caroline R. Cothern, Maggie P. Ducote, Thomas M. Martin, Melissa A. Linden, Robert C. Noland, David H. Burk, Samuel D. Dupuy, Michael D. Karlstad, Krisztian Stadler, Sarah S. Hirschbeck, Thanh D. Do, Anastasia Coldren, Marcela Brissova, Teayoun Kim, Kirk M. Habegger, Sujoy Ghosh, Zane A. Vickery, Qudus Sarumi, Shawn R. Campagna, Susan J. Burke
View: Text | PDF
Research Article Endocrinology Metabolism

Reduced peroxisomal function increases insulin secretion, promotes insulin oxidation, and impairs β cell maturity

  • Text
  • PDF
Abstract

Given the central role of peroxisomes in lipid metabolism and redox homeostasis, we hypothesized that peroxisomal activity is critical for sustaining β cell function and identity. Pex5 deletion models were employed to investigate the loss of peroxisomal function on glucose-stimulated insulin secretion (GSIS), oxidative stress, and β cell maturity markers. Peroxisome deficiency in male mice resulted in elevated GSIS. Glucose intolerance developed despite increased insulin secretion. Ion mobility mass spectrometry revealed oxidation of insulin proteins and a truncated insulin 2–derived peptide in islets from mice with a tissue-specific deficiency in peroxisomes. Peroxisome loss of function increased multiple markers of oxidative stress, including altered metabolite profiles, lipid peroxidation, and protein carbonylation. These findings revealed that increased secretion of oxidized insulin protein is insufficient to regulate whole-body glucose homeostasis. Peroxisome deficiency also reduced markers of β cell maturity. Based on these outcomes, we identified the peroxisome organelle as a key regulatory component of glucose homeostasis by protecting insulin from oxidative modification and degradation and by supporting maintenance of mature β cells.

Authors

J. Jason Collier, Caroline R. Cothern, Maggie P. Ducote, Thomas M. Martin, Melissa A. Linden, Robert C. Noland, David H. Burk, Samuel D. Dupuy, Michael D. Karlstad, Krisztian Stadler, Sarah S. Hirschbeck, Thanh D. Do, Anastasia Coldren, Marcela Brissova, Teayoun Kim, Kirk M. Habegger, Sujoy Ghosh, Zane A. Vickery, Qudus Sarumi, Shawn R. Campagna, Susan J. Burke

×

Figure 2

Peroxisomes are critical for maintenance of glucose tolerance and β cell function in male mice.

Options: View larger image (or click on image) Download as PowerPoint
Peroxisomes are critical for maintenance of glucose tolerance and β cell...
(A) Fed blood glucose values in male Pex5CON, Pex5Pdx1–/–, and Pex5Ins1–/– mice from 8 to 30 weeks of age; n = 26–34. (B–E) i.p. GTTs in 8- (n = 9–14), 12- (n = 22), 20- (n = 15–16), and 30- (n = 8–19) week-old mice. (F) Oral GTT in 15-week-old mice; n = 11–25. (G–I) Fasting blood glucose, glucose infusion rate, and plasma insulin during a hyperglycemic clamp in 18-week-old mice; n = 4. (J–M) Glucose-mediated (16.7 mM glucose; G 16.7) and KCl-mediated (20 mM; KCl 20) insulin secretion and corresponding AUC calculations in isolated islets from 12- and 30-week-old mice, respectively; n = 6. (N) Insulin content in islets used for experiments in J–M; n = 6–13. (O) i.p. GTT in 30-week-old male Pex5CON and Pex5Ins1–/– mice; n = 29–31. (P) Oral GTT in 42-week-old mice; n = 9. (Q and R) Glucose-mediated (16.7 mM glucose; G 16.7) and KCl-mediated (20 mM; KCl 20) insulin secretion and corresponding AUC calculation in isolated islets from 30-week-old mice; n = 4. (S) Insulin content in islets used for the experiment in Q and R. (T) GSIS (2 mM versus 20 mM glucose) in 832/13 cells treated for 48 hours with siRNA control (siCTRL) or siRNA duplexes targeting the Pex5 gene (siPex5) prior to glucose treatment; n = 3 individual experiments with 4 replicates for each experiment. ns, not significant; *P < 0.05; **P < 0.01; ****P < 0.0001. P values shown on graph represent AUC versus controls. One-way ANOVA with multiple comparisons (K, M, N, and R) or 2-tailed Student’s t test (S and T); wo, weeks old.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts